Clinical Trials in Chicago

Showing 4621-4640 of 20,493 trials

RECRUITINGNA2.2 miles

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

NCT07061691

This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.

StrokeHealthy

Shirley Ryan AbilityLab20 participantsStarted Jul 2025

Chicago, Illinois, United States

TERMINATEDPhase 22.2 miles

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

NCT03501979

A phase 2 non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab with capecitabine for the treatment of leptomeningeal metastases in HER2-neu positive breast cancer.

Metastatic Breast CancerLeptomeningeal Disease

University of Alabama at Birmingham17 participantsStarted Feb 2019

Birmingham, Alabama, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +6 more locations

Active Not RecruitingPhase 32.2 miles

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

NCT04437511

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease. Additional participants will be enrolled to an addendum safety cohort. The participants will be administered open-label donanemab. Trial participants who were dosed with donanemab in the main study will be enrolled to a 3-year follow up addendum. No study drug will be administered during this follow up.

Alzheimer Disease

Eli Lilly and Company1,736 participantsStarted Jun 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +271 more locations

WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Find Trials by Condition in Chicago

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

A Study to Investigate the Effect of a Multivitamin, Multi-nutrient Supplement on Mental and Emotional Wellbeing

The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations

MarginProbe 2.0 Data Collection Protocol

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes